avoid it? A recent survey of 252 human cell lines submitted to the state-sponsored cell bank in Germany, revealed that 18% of them contained intraspecies contaminants. Clearly, this is just the tip of an iceberg, given the large number of lines yet to be tested. Why should this happen? There is an international "swap shop" of cell lines generated as a result of the collaborative nature of modern science, so it is easy to see, given the scale of the operation, the opportunities for misidentification which might arise by simple errors and genuine mistakes. Could it not also be that, since the problem was first publicised some quarter of a century ago, people have gradually forgotten to pass on this experience to the considerable numbers of graduate students who ought to have been tutored on the fundamental importance of good technique? Although it is possible to sympathise, it is not possible to condone this lack of proper training. It may even be that people regard the cells they are working with as representing no more than a simple substrate, whose maintenance is left to a junior member of the team.
What of the consequences? It is obvious that a mislabelled cell culture is bound to generate misleading and invalid information, and that, when instances are discovered, some form of retraction is appropriate. However, as was pointed out recently, 3 there seems to be an incurable persistence in continuing to report work with dubious cells lines. In 1993, the widely used cell line KB was shown unambiguously to be HeLa 4 but, since then, over 350 papers have been published on this material, implying that the observations had been carried out on a cell line derived from an oral carcinoma. What does this tell us about the review process?
With regard to eliminating this problem, there are a number of steps that can be taken. Firstly, it would be helpful if authors provided, before publication, evidence of the provenance of their materials. A recent assessment of papers previously published in Cancer Research 5 revealed that 33 papers reported on 121 cell lines, of which 52 were originally derived from repositories, and 12 from other laboratories, while the origin of the remaining 57 was not stated.
The second and most powerful tool to establish validity would follow from procedures for authentication. Ever since the pioneering studies of Gartler 1 and Nelson-Rees et al., 6 attempts have been made to provide readily accessible procedures for cellular identification based, for example, on an assay for an alloenzyme fingerprint. 7 A recently published international study reported by Masters et al., 8 provides just such a powerful, relatively inexpensive, and commercially available way forward. 8 This study, which also confirmed the widespread existence of contamination, used modern forensic techniques, based on the detection of short tandem repeats, to characterise the DNA from 253 cell lines. It is now possible to verify the status of the cultures that are used in any study and, in the circumstances where cells are exchanged between laboratories, to confirm that the cells are what they are purported to be. The third step, as suggested by Masters et al., would be that the editors of scientific journals would demand evidence of genetic characterisation as a mandatory requirement for consideration for publication. Indeed, it is to be hoped that this recommendation will be taken up with enthusiasm, now that we have the tools to avert a situation whereby a large volume of authentic information based on cellular studies could fall into disrepute by association with sloppy science.
Colin Arlett Department of Biological Sciences
Brunel University Uxbridge Middlesex UP8 3PH UK
